SCHEMBL3917818

SCHEMBL3917818

O=C(CI)NS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4969215 0.72 PHF8 (0.38)
SCHEMBL23816237 0.69
SCHEMBL8580457 0.69
SCHEMBL3911474 0.67
SCHEMBL6498969 0.67
SCHEMBL14307468 0.67
SCHEMBL19383636 0.67
SCHEMBL817079 0.67
SCHEMBL8583300 0.67
SCHEMBL134099 0.67 ALDH1A1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1673399-B1 DETECTING AND PROFILING MOLECULAR COMPLEXES MONOGRAM BIOSCIENCES INC (US) 2017-04-05 EP disclosed
US-9110075-B2 Compositions for analyzing proteins MONOGRAM BIOSCIENCES, INC. (US) 2015-08-18 US disclosed
EP-2068828-A2 BIODEGRADABLE OCULAR IMPLANTS AND METHODS FOR TREATING OCULAR CONDITIONS SurModics, Inc. (US) 2009-06-17 EP disclosed
EP-2015794-A2 HYDROPHILIC SHAPE MEMORY INSERTABLE MEDICAL ARTICLES SurModics, Inc. (US) 2009-01-21 EP disclosed
WO-2009005718-A1 POLYPEPTIDE MICROPARTICLES HAVING SUSTAINED RELEASE CHARACTERISTICS, METHODS AND USES SURMODICS, INC. (US) 2009-01-08 WO disclosed
EP-1937327-A1 NATURAL BIODEGRADABLE MATRICES AND USES THEREOF SurModics, Inc. (US) 2008-07-02 EP disclosed
WO-2008073295-A2 LATENT STABILIZATION OF BIOACTIVE AGENTS RELEASABLE FROM IMPLANTABLE MEDICAL ARTICLES SURMODICS, INC. (US) 2008-06-19 WO disclosed
EP-1926505-A1 IN VIVO FORMED MATRICES INCLUDING NATURAL BIODEGRADABLE POLYSACCHARIDES AND OPHTHALMIC USES THEREOF SurModics, Inc. (US) 2008-06-04 EP disclosed
EP-1926509-A1 COATINGS AND ARTICLES INCLUDING NATURAL BIODEGRADABLE POLYSACCHARIDES SurModics, Inc. (US) 2008-06-04 EP disclosed
EP-1926504-A1 COATINGS AND ARTICLES INCLUDING NATURAL BIODEGRADABLE POLYSACCHARIDES SurModics, Inc. (US) 2008-06-04 EP disclosed
WO-2005115490-A2 NATURAL BIODEGRADABLE POLYSACCHARIDE COATINGS FOR MEICAL ARTICLES SURMODICS, INC. (US) 2005-12-08 WO disclosed
WO-2005113034-A1 NATURAL BIODEGRADABLE POLYSACCHARIDES COATINGS FOR MEDICAL ARTICLES SURMODICS, INC. (US) 2005-12-01 WO disclosed
US-5827672-A Human monocyte elastase inhibitor antibodies CENTER FOR BLOOD RESEARCH, INC. (US) 1998-10-27 US disclosed
EP-0460072-B1 HUMAN ELASTASE INHIBITOR BLOOD RES CENTER (US) 1998-02-04 EP disclosed
US-5663299-A Human monocyte elastase inhibitor CENTER FOR BLOOD RESEARCH, INC. (US) 1997-09-02 US disclosed
WO-1996010418-A1 HUMAN MONOCYTE ELASTASE INHIBITOR CENTER FOR BLOOD RESEARCH, INC. (US) 1996-04-11 WO disclosed
US-5370991-A Forms complex with elastase and inhibits elastinolytic activity of elastase THE CENTER FOR BLOOD RESEARCH, INC. (US) 1994-12-06 US disclosed
EP-0460072-A4 HUMAN ELASTASE INHIBITOR 1992-02-12 EP disclosed
EP-0460072-A1 HUMAN ELASTASE INHIBITOR CENTER FOR BLOOD RESEARCH, INC. (US) 1991-12-11 EP disclosed
WO-1990009737-A1 HUMAN ELASTASE INHIBITOR THE CENTER FOR BLOOD RESEARCH (US) 1990-09-07 WO disclosed